Drugmakers Intensify Battle for Share in Booming Hypertension Market

SEOUL, Jan. 23 (Korea Bizwire) — South Korea’s pharmaceutical industry has opened the year with intensifying competition in the hypertension treatment market, as drugmakers race to secure an early foothold in one of the country’s largest and most lucrative therapeutic segments. With an estimated 10 million patients and a market valued at roughly 2.4 trillion won, [...]